465
Views
12
CrossRef citations to date
0
Altmetric
Original article

Rotigotine transdermal patch in combination therapy for Parkinson’s disease – observations in routine clinical practice

&
Pages 1899-1905 | Accepted 04 Aug 2011, Published online: 25 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Silvia Rota, Iro Boura, Lucia Batzu, Nataliya Titova, Peter Jenner, Cristian Falup-Pecurariu & K Ray Chaudhuri. (2020) ‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine. Expert Review of Neurotherapeutics 20:9, pages 953-965.
Read now
Francesc Valldeoriola, Antonio Salvador, José Maria Gómez-Arguelles, José Marey, Miguel Moya, Ángel Ayuga & Francisco Ramírez. (2018) The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study. International Journal of Neuroscience 128:4, pages 369-375.
Read now
Theresa A Zesiewicz & Pablo Martinez-Martin. (2013) Effects of rotigotine transdermal system on non-motor symptoms in Parkinson’s disease: an overview. Expert Review of Neurotherapeutics 13:12, pages 1329-1342.
Read now

Articles from other publishers (9)

P. Tall, M. A. Qamar, L. Batzu, V. Leta, C. Falup-Pecurariu & K. Ray Chaudhuri. (2023) Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease. Journal of Neural Transmission 130:11, pages 1443-1449.
Crossref
Vanessa Raeder, Iro Boura, Valentina Leta, Peter Jenner, Heinz Reichmann, Claudia Trenkwalder, Lisa Klingelhoefer & K. Ray Chaudhuri. (2021) Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience. CNS Drugs 35:2, pages 215-231.
Crossref
James E. Frampton. (2019) Rotigotine Transdermal Patch: A Review in Parkinson’s Disease. CNS Drugs 33:7, pages 707-718.
Crossref
Miguel Rosa-Grilo, Mubasher A. Qamar, Raquel N. Taddei, Javier Pagonabarraga, Jaime Kulisevsky, Anna Sauerbier & K. Ray Chaudhuri. (2017) Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?. npj Parkinson's Disease 3:1.
Crossref
Rejko Krüger, Rüdiger Hilker, Christian Winkler, Michael Lorrain, Matthias Hahne, Christoph Redecker, Paul Lingor & Wolfgang H. Jost. (2015) Advanced stages of PD: interventional therapies and related patient-centered care. Journal of Neural Transmission 123:1, pages 31-43.
Crossref
Iria Rodriguez Constenla, Antonio Pato Pato, Icíar Cimas Hernando & José Ramón Lorenzo Gonzalez. (2014) Safety and Tolerability of Transdermal Rotigotine in a Clinical Practice Cohort for 2 Years. World Journal of Neuroscience 04:05, pages 443-449.
Crossref
Peter Jenner. (2013) Wearing Off, Dyskinesia, and the Use of Continuous Drug Delivery in Parkinson's Disease. Neurologic Clinics 31:3, pages S17-S35.
Crossref
Johan LökkSeyed-Mohammad Fereshtehnejad. (2013) Managing palliative care in Parkinson’s disease from diagnosis to end-stage disease: what the clinician should know. Neurodegenerative Disease Management 3:2, pages 169-183.
Crossref
Katherine A. Lyseng-Williamson, Mark Sanford & Lesley J. Scott. (2013) Rotigotine transdermal patch: a guide to its use in Parkinson?s disease and restless leg syndrome. Drugs & Therapy Perspectives 29:3, pages 57-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.